Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations - 28/04/12
Doi : 10.1016/j.jaci.2012.02.048
Søren Pedersen, MD, PhD, Dr Med Sci a, ⁎ 
, Paul M. O’Byrne, MB, FRCP(C) b
, Paul M. O’Byrne, MB, FRCP(C) b a University of Southern Denmark and the Paediatric Research Unit, Kolding Hospital, Kolding, Denmark
b Firestone Institute for Respiratory Health, St Joseph’s Healthcare, and the Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Corresponding author: Søren Pedersen, MD, PhD, Dr Med Sci, Paediatric Research Unit, Kolding Hospital, Skovvangen 2-8, 6000 Kolding, Denmark.Key words : Inhaled corticosteroid, long-acting β2-agonist, asthma, exacerbation
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: S. Pedersen is on advisory boards for GlaxoSmithKline, Boehringer Ingelheim, and Nycomed and receives lecture fees from GlaxoSmithKline. P. M. O’Byrne is on advisory boards for AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Merck, and Almiral; receives speakers’ honoraria from AstraZeneca; and receives research support from AstraZeneca, Asmacure, Genentech, Amgen, Ono, and AIM. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 129 - N° 5
P. 1280-1281 - mai 2012 Retour au numéro
Article précédent
- The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population
- Karen E. Wells, Edward L. Peterson, Brian K. Ahmedani, Richard K. Severson, Julie Gleason-Comstock, L. Keoki Williams
- A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis
- Warner Carr, Jonathan Bernstein, Phil Lieberman, Eli Meltzer, Claus Bachert, David Price, Ullrich Munzel, Jean Bousquet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?